A high-throughput microfluidic assay for SH2 domain-containing inositol 5-phosphatase 2

Assay and Drug Development Technologies

Volumn 4, Issue 2, 2006, Pages 174-183

  Rowe, Todd ^a   Hale, Clarence ^a   Zhou, Aileen ^b,c   Kurzeja, Robert J M ^a   Ali, Arisha ^a   Menjares, Anthony ^a   Wang, Mingham ^a   McCarter, John D ^a  

^a AMGEN INC   (United States)

^b Caliper Life Sciences   (United States)

^c FIVE PRIME THERAPEUTICS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; FLUORESCENT DYE; PHOSPHATASE; PHOSPHATIDYLINOSITIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE INHIBITOR; PHOSPHOTRANSFERASE; SH2 DOMAIN CONTAINING INOSITOL 5 PHOSPHATASE 2; UNCLASSIFIED DRUG; DIMETHYL SULFOXIDE; INPPL1 PROTEIN, HUMAN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5-TRIPHOSPHATE; POLYPHOSPHOINOSITIDE; RECOMBINANT PROTEIN;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ELECTRIC FIELD; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME PURIFICATION; ESCHERICHIA COLI; HIGH THROUGHPUT SCREENING; IMMUNOASSAY; MICROFLUIDIC ANALYSIS; MOLECULAR LIBRARY; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; SENSITIVITY ANALYSIS; CHEMISTRY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; SIGNAL TRANSDUCTION; THIN LAYER CHROMATOGRAPHY;

1-PHOSPHATIDYLINOSITOL 3-KINASE; CHROMATOGRAPHY, THIN LAYER; DIMETHYL SULFOXIDE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MICROFLUIDIC ANALYTICAL TECHNIQUES; PHOSPHATIDYLINOSITOL PHOSPHATES; PHOSPHORIC MONOESTER HYDROLASES; PTEN PHOSPHOHYDROLASE; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 33744531156     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2006.4.175     Document Type: Article

References (19)

1. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C; American Heart Association; National Heart, Lung, and Blood Institute: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004;109: 433-438.
2. DeFronzo RA, Ferrannini E: Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.
3. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806.
4. Saltiel AR: New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell 2001;104: 517-529.
5. Di Cristofano A, Pesce B, Cordon-Cardo C, Pandolfi PP: PTEN is essential for embryonic development and tumour suppression. Nat Genet 1998;19:348-355.
6. Sasaoka T, Hori H, Wada T, Ishiki M, Haruta T, Ishihara H, Kobayashi M: SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes. Diabetologia 2001;44:1258-1267.
7. Blero D, De Smedt F, Pesesse X, Paternotte N, Moreau C, Payrastre B, Erneux C: The SH2 domain containing inositol 5-phosphatase SHIP2 controls phosphatidylinositol 3,4,5-trisphosphate levels in CHO-IR cells stimulated by insulin. Biochem Biophys Res Commun 2001;282:839-843. Erratum in: Biochem Biophys Res Commun 2001;284:1090.
8. Wada T, Sasaoka T, Funaki M, Hori H, Murakami S, Ishiki M, Haruta T, Asano T, Ogawa W, Ishihara H, Kobayashi M: Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5-phosphatase catalytic activity. Mol Cell Biol 2001;21:1633-1646.
9. Sasaoka T, Fukui K, Wada T, Murakami S, Kawahara J, Ishihara H, Funaki M, Asano T, Kobayashi M: Inhibition of endogenous SHIP2 ameliorates insulin resistance caused by chronic insulin treatment in 3T3-L1 adipocytes. Diabetologia 2005;48:336-344.
10. Marion E, Kaisaki PJ, Pouillon V, Gueydan C, Levy JC, Bodson A, Krzentowski G, Daubresse JC, Mockel J, Behrends J, Servais G, Szpirer C, Kruys V, Gauguier D, Schurmans S: The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man. Diabetes 2002;51:2012-2017.
11. Kagawa S, Sasaoka T, Yaguchi S, Ishihara H, Tsuneki H, Murakami S, Fukui K, Wada T, Kobayashi S, Kimura I, Kobayashi M: Impact of SRC homology 2-containing inositol 5-phosphatase 2 gene polymorphisms detected in a Japanese population on insulin signaling. J Clin Endocrinol Metab 2005;90:2911-2919.
12. Clement S, Krause U, Desmedt F, Tanti JF, Behrends J, Pesesse X, Sasaki T, Penninger J, Doherty M, Malaisse W, Dumont JE, Le Marchand-Brustel Y, Erneux C, Hue L, Schurmans S: The lipid phosphatase SHIP2 controls insulin sensitivity. Nature 2001;409:92-97. Erratum in: Nature 2004;431:878.
13. Sleeman MW, Wortley KE, Lai KM, Gowen LC, Kintner J, Kline WO, Garcia K, Stitt TN, Yancopoulos GD, Wiegand SJ, Glass DJ: Absence of the lipid phosphatase SHIP2 confers resistance to dietary obesity. Nat Med 2005;11: 199-205. Erratum in: Nat Med 2005;11:353.
14. Fukui K, Wada T, Kagawa S, Nagira K, Ikubo M, Ishihara H, Kobayashi M, Sasaoka T: Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes 2005;54:1958-1967.
15. Drees BE, Weipert A, Hudson H, Ferguson CG, Chakravarty L, Prestwich GD: Competitive fluorescence polarization assays for the detection of phosphoinositide kinase and phosphatase activity. Comb Chem High Throughput Screen 2003;6:321-330.
16. Zhang JH, Chung TD, Oldenburg KR: A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J Biomol Screen 1999;4: 67-73.
17. Pesesse X, Moreau C, Drayer AL, Woscholski R, Parker P, Erneux C: The SH2 domain containing inositol 5-phosphatase SHIP2 displays phosphatidylinositol 3,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate 5-phosphatase activity. FEBS Lett 1998;437:301-303.
18. Tsujishita Y, Guo S, Stolz LE, York JD, Hurley JH: Specificity determinants in phosphoinositide dephosphorylation: crystal structure of an archetypal inositol polyphosphate 5-phosphatase. Cell 2001;105:379-389.
19. Martin B, Pallen CJ, Wang JH, Graves DJ: Use of fluorinated tyrosine phosphates to probe the substrate specificity of the low molecular weight phosphatase activity of calcineurin. J Biol Chem 1985;260:14932-14937.